These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mechanisms for the maintenance of ventricular fibrillation: the nonuniform dispersion of refractoriness, restitution properties, or anatomic heterogeneities? Qin H; Huang J; Rogers JM; Walcott GP; Rollins DL; Smith WM; Ideker RE J Cardiovasc Electrophysiol; 2005 Aug; 16(8):888-97. PubMed ID: 16101633 [TBL] [Abstract][Full Text] [Related]
43. β Zhao YH; Huang HX; Liu P; Du YH; Wang P; Wang W; Wu Y; Wang L; Ma CS; Liu HR Exp Physiol; 2017 Jan; 102(1):25-33. PubMed ID: 27862484 [TBL] [Abstract][Full Text] [Related]
45. [Ion channels and arrhythmias]. Borchard U; Hafner D Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780 [TBL] [Abstract][Full Text] [Related]
46. [Electrophysiological effects of berbamine on ischemic ventricular tachyarrhythmia]. Guo ZB; Cao HY; Xu Z; Li Q Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):44-7. PubMed ID: 1950584 [TBL] [Abstract][Full Text] [Related]
47. Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers. Gillis AM; Mathison HJ; Kulisz E; Lester WM J Pharmacol Exp Ther; 2000 Jan; 292(1):381-6. PubMed ID: 10604974 [TBL] [Abstract][Full Text] [Related]
48. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol. Fiset C; Drolet B; Hamelin BA; Turgeon J J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319 [TBL] [Abstract][Full Text] [Related]
49. Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits. Rials SJ; Xu X; Wu Y; Marinchak RA; Kowey PR Am J Physiol; 1998 Oct; 275(4):H1216-24. PubMed ID: 9746469 [TBL] [Abstract][Full Text] [Related]
50. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Rees SA; Curtis MJ Circulation; 1993 Jun; 87(6):1979-89. PubMed ID: 8504513 [TBL] [Abstract][Full Text] [Related]
51. Regional electrophysiological effects of left ventricular hypertrophy in isolated rabbit hearts under normal and ischaemic conditions. Wolk R; Sneddon KP; Dempster J; Kane KA; Cobbe SM; Hicks MN Cardiovasc Res; 2000 Oct; 48(1):120-8. PubMed ID: 11033114 [TBL] [Abstract][Full Text] [Related]
52. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects. Kirchhof PF; Fabritz CL; Franz MR Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478 [TBL] [Abstract][Full Text] [Related]
53. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog. Leboeuf J; Basiez M; Massingham R Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882 [TBL] [Abstract][Full Text] [Related]
54. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872. Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331 [TBL] [Abstract][Full Text] [Related]
55. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Farkas A; Qureshi A; Curtis MJ Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833 [TBL] [Abstract][Full Text] [Related]
56. Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts. Aydin O; Becker R; Kraft P; Voss F; Koch M; Kelemen K; Katus HA; Bauer A Europace; 2007 Nov; 9(11):1094-8. PubMed ID: 17684067 [TBL] [Abstract][Full Text] [Related]
57. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Koumi S; Backer CL; Arentzen CE Circulation; 1995 Jul; 92(2):164-74. PubMed ID: 7600647 [TBL] [Abstract][Full Text] [Related]
58. The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models. O'Connor KM; Friehling TD; Kowey PR Am Heart J; 1989 Apr; 117(4):848-53. PubMed ID: 2929400 [TBL] [Abstract][Full Text] [Related]
59. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031 [TBL] [Abstract][Full Text] [Related]